阿司匹林聯(lián)合復(fù)方丹參滴丸治療冠心病的效果分析

打開文本圖片集

【摘要】目的：探討阿司匹林以及復(fù)方丹參滴丸兩種藥物對冠心病的效果。方法：選取2020年5月—2022年4月我院的100例冠心病患者，隨機(jī)分成兩組。對照組服用100 mg劑量的阿司匹林，觀察組聯(lián)用10 粒劑量的復(fù)方丹參滴丸。結(jié)果：觀察組經(jīng)過治療有48例患者表現(xiàn)出有效果，而對照組是41例有效果，組間比較觀察組的優(yōu)勢更加明顯（P0.05），治療后，再次檢測顯示，兩組的LVESV、LVEDD、LVEF和LVESD數(shù)據(jù)均有了明顯的改善（P0.05），治療后，檢測兩組顯示PAGM、MPV和TXB2水平均發(fā)生較大的變化，即降低（P

【關(guān)鍵詞】阿司匹林；復(fù)方丹參滴丸；冠心病

Effect of Aspirin Combined with Compound Danshen Dropping Pills on Coronary Heart Disease

QIAO Caixia

Ganquan Traditional Chinese Medicine Hospital， Yan’an， Shaanxi 716100， China

【Abstract】Objective To investigate the effect of aspirin combined with compound salvia miltiorrhiza dropping pills on coronary heart disease. Methods 100 patients with coronary heart disease in our hospital from May 2020 to April 2022 were randomly divided into two groups. The control group was treated with aspirin alone， Observation group combined with compound salvia miltiorrhiza dropping pills. Results After treatment， 48 patients in the observation group showed effective results， while 41 patients in the control group showed effective results. The advantages of the observation group were more obvious （P0.05）. After treatment， re detection showed that the LVESV， LVEDD， LVEF and LVESD data of the two groups had significantly improved （P0.05）. After treatment， the levels of PAGM， MPV and TXB2 in the two groups showed significant changes， that is， decreased （P

【Key Words】Aspirin； Compound Danshen dropping pills； Coronary heart disease

冠心病患者因?yàn)閯用}血管內(nèi)皮細(xì)胞受到損傷、動脈壁硬化，導(dǎo)致細(xì)小動脈發(fā)生廣泛收縮痙攣，外源性的凝血系統(tǒng)激活，使外周阻力明顯增加，血流減慢、甚至淤滯，從而導(dǎo)致內(nèi)源性凝血系統(tǒng)進(jìn)一步激活[1-2]。（剩余4276字）